x

Search for a clinical trial

* (*) mandatory field

28 Result(s)

Sort by

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Terminated trial = Terminated trial; Funded by an IRDiRC member = ; Study involving ERN members in at least two Member States =

National clinical trial(s)

SWEDEN

Region Stockholm
ADDRESS: NOT PROVIDED - SE

FRANCE

BOURGOGNE-FRANCHE-COMTE
BESANÇON

FRANCE

ILE-DE-FRANCE
VILLEJUIF

Recruiting trial
Ongoing trial
AcSé : Secured Access to Pembrolizumab for Adult Patients With Selected Rare Cancer Types (Phase II)
CLCC Institut Gustave Roussy
Département d'Innovation Thérapeutique et d'Essais Précoces

ITALY

EMILIA ROMAGNA
MELDOLA

ITALY

EMILIA ROMAGNA
MELDOLA

Recruiting trial
Ongoing trial
LUTHREE - Randomized Phase II Trial in sstr2 Positive Tumors to Optimize the Interval Between Cycles of PRRT With 177lu-dotatate Study
IRST - Istituto Scientifico Romagnolo per lo studio e la cura dei Tumori
UO Medicina Nucleare

SPAIN

Madrid
ADDRESS: NOT PROVIDED - ES

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

Recruiting trial
Ongoing trial
Funded by an IRDiRC memberGallium 68 Pentixafor in Patients With Neuroendocrine Tumors
Institution: Information not provided - US

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Ongoing trial
STEP: Sorafenib Long Term Extension Program - BE
Cliniques universitaires Saint-Luc - UCLouvain
Pneumologie-Oncologie thoracique

ITALY

LAZIO
ROMA

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

Recruiting trial
Ongoing trial
Funded by an IRDiRC memberNivolumab and Ipilimumab in Treating Patients With Rare Tumors
Institution: Information not provided - US

Multinational clinical trial(s)

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US